Research institute
At the Drug Development Unit at The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust in London, the first patient in Phoenix’s first in human “ACTivate Trial” has received ACT® in combination with chemotherapy for treatment of hepatic metastases associated with colorectal and pancreatic cancer.
Vaccitech Ltd announced that its strategic collaboration with the Ludwig Institute for Cancer Research, Vaccitech Oncology Limited, has entered into a clinical partnership with Cancer Research UK to develop VOLT’s VTP-600 immunotherapy as a treatment option for patients with non-small cell lung cancer.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
Seminal report focuses on hope, hype, promise, and peril of AI use in medical arena
As a valued member of our BioSpace community, we are eager to hear more from you and other readers as we head into 2020. We want to know if you have grown in your career over the past year.
The Beacon optofluidic technology will be used to speed the identification of lifesaving treatments for deadly viruses including Ebola, Lassa and others.
Only 28 per cent of people believe cancers can be controlled long term – yet the average patient now lives more than 10 years from diagnosis
Blood tests to be used to read entire genetic code of people attending a GP surgery, to look for faulty genes relating to cancer and heart disease
Researchers from Regenstrief Institute and Indiana University are building and expanding global relationships and collaborations in the fields of public health and health informatics.
Scientists have found that faults in the blood-brain barrier lead to increased immune activity in the brain of mice. The researchers published the findings in two scientific papers in Science Translational Medicine.
PRESS RELEASES